Malignant Neoplasm Clinical Trials in New Brunswick, New Jersey

5 studies are recruiting for malignant neoplasm in New Brunswick, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

   Researchers are looking for new ways to treat children with hepatoblastoma or rhabdomyosarcoma (RMS) that has relapsed or is refractory: * Hepatoblastoma is a common liver cancer in babies and very young children * RMS is a cancer that starts in muscle cells, often in a child's head and neck, bladd…

   Stage

   Phase 1

   Ages

   0 to 17

   Site

   Rutgers Cancer Institute of New Jersey ( Site 3008), New Brunswick, New Jersey

   Locations

   63 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06941272 on ClinicalTrials.gov

2. A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

   Researchers are looking for new ways to treat children with relapsed or refractory solid tumors: * Relapsed means the cancer came back after treatment * Refractory means the cancer did not respond (get smaller or go away) to treatment * Solid tumors are cancers mostly in body organs and tissues, no…

   Stage

   Phase 1

   Ages

   0 to 17

   Site

   Rutgers Cancer Institute of New Jersey ( Site 4008), New Brunswick, New Jersey

   Locations

   26 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07630974 on ClinicalTrials.gov

3. A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

   Researchers are looking for new ways to treat certain advanced or metastatic solid tumors. The goal of this study is to learn about the safety of MK-4716 and if people tolerate it when taken alone or with other treatments.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Rutgers Cancer Institute of New Jersey ( Site 0052), New Brunswick, New Jersey

   Locations

   21 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07247110 on ClinicalTrials.gov

4. Project: Every Child for Younger Patients With Cancer

   This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

   Stage

   Not phased

   Ages

   Up to 25

   Site

   Saint Peter's University Hospital, New Brunswick, New Jersey

   Locations

   279 in total

   Run by

   Children's Oncology Group

   See if you can join NCT02402244 on ClinicalTrials.gov

5. Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

   This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine the entire genetic makeup of a specific organism or cell type. Genomic sequencing can be used to find changes i…

   Stage

   Not phased

   Ages

   1 and older

   Site

   Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

   Locations

   11 in total

   Run by

   Rutgers, The State University of New Jersey

   See if you can join NCT02688517 on ClinicalTrials.gov